短发夹状RNA抑制AKT2基因表达增强卵巢上皮性癌细胞对紫杉醇敏感性的研究
被引量:3
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
2006年第12期847-849,共3页
Chinese Journal of Obstetrics and Gynecology
基金
国家自然科学基金资助项目(30571950)
国家重点基础研究发展计划资助项目(2002CB513107)
参考文献13
-
1Hammond SM,Bernstein E,Beach D,et al.An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.Nature,2000,404:293-296.
-
2Arboleda MJ,Lyons JF,Kabbinavar FF,et al.Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins,increased invasion,and metastasis of human breast and ovarian cancer cells.Cancer Res,2003,63:196-206.
-
3Tazi J,Forne T,Jeanteur P,et al.Mammalian U6 small nuclear RNA undergoes 3′ end modifications within the spliceosome.Mol Cell Biol,1993,13:1641-1650.
-
4Potter PM,McKenzie PP,Hussain N,et al.Construction of adenovirus for high level expression of small RNAs in mammalian cells.Application to a Bcl-2 ribozyme.Mol Biotechnol,2000,15:105-114.
-
5Ilves H,Barske C,Junker U,et al.Retroviral vectors designed for targeted expression of RNA polymerase Ⅲ-driven transcripts:a comparative study.Gene,1996,171:203-208.
-
6Franke TF,Hornik CP,Segev L,et al.PI3K/Akt and apoptosis:size matters.Oncogene,2003,22:8983-8998.
-
7Page C,Lin HJ,Jin Y,et al.Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.Anticancer Res,2000,20:407-416.
-
8Cheng JQ,Godwin AK,Bellacosa A,et al.AKT2,a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases,is amplified in human ovarian carcinomas.Proc Natl Acad Sci U S A,1992,89:9267-9271.
-
9Yuan ZQ,Sun M,Feldman RI,et al.Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.Oncogene,2000,19:2324-2330.
-
10Bellacosa A,de Feo D,Godwin AK,et al.Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.Int J Cancer,1995,64:280-285.
二级参考文献8
-
1Charles JS. He pezcoller lecture: cancer cell cycles revisited, Cancer Res, 2000, 60: 3689-3695.
-
2Lioyd RV, Erickson LA, Long J, et al. A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol, 1999,154:313-323.
-
3Tatjana V, Achenbach, Rolf Muller, et al. Synergistic antitumor effect of chemotherapy and antisense-mediated ablation of the cell cycle inhibitor p27, Clin Cancer Res,2000,6: 3006-3014.
-
4Koike C, McKee TD, Pluen A, et al. Solid stress facilitates spheroid formation: potential involvement of hyaluronan. Br J Cancer, 2002, 75:947-953.
-
5Frankel A, Buckman R, Kerbel RS. Abrogation of taxol-induced G2-Marrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res, 1997,57:2388-2393.
-
6Hamilton G. Multicellullar spheroids as an in vitro tumor model. Cancer Lett, 1998,131:29-34.
-
7St Croix B,Florenes VA, Rak JW ,et al. Impact of the cyclin-dependent kinase inhibitor p27 on resistance of tumor cells to anti-cancer agents. Nature Med, 1996, 2:1204-1210.
-
8Alan MG, Deborah LS, Marius ZR. Nucleic acid therapeutics: state of the art and future propects. Blood, 1998,92: 712-736.
共引文献11
-
1高红旺,张慧锋.紫杉醇在抗癌领域的研究进展[J].吉林医药学院学报,2005,26(2):117-118.
-
2李晓翠,曹丽,傅庆诏.反义基因治疗在卵巢癌中的应用[J].国外医学(肿瘤学分册),2005,32(10):790-793. 被引量:2
-
3邢辉,李静,杨晓葵,高庆蕾,翁丹卉,卢运萍,马丁.人卵巢癌多细胞球体的P-gp蛋白表达与p27蛋白表达的相关性研究[J].中国肿瘤临床,2006,33(12):670-673. 被引量:2
-
4曹琦,丰有吉.糖原合酶激酶-3β活性改变对卵巢癌细胞周期的调节及其对泰素增敏作用的研究[J].中华医学杂志,2006,86(21):1497-1499. 被引量:2
-
5宋晓红,邢辉,翁丹卉,马晓黎,卢运萍,周剑锋,马丁.两位点短发卡状RNA诱导AKT2基因沉默在卵巢癌细胞紫杉醇敏感性中的应用研究[J].肿瘤,2007,27(1):5-8. 被引量:7
-
6马晓黎,邢辉,翁丹卉,宋晓红,卢运萍,马丁.真核表达Survivin基因对卵巢癌细胞紫杉醇敏感性的影响[J].华中科技大学学报(医学版),2007,36(2):224-227. 被引量:2
-
7翁丹卉,邢辉,邓友星,梁逢奇,黄磊,李芳,马丁,卢运萍.短发卡状RNA抑制AKT2基因表达增强卵巢癌细胞对紫杉醇敏感性的研究[J].中华肿瘤防治杂志,2007,14(14):1041-1045. 被引量:4
-
8项涛,夏曦,卢运萍,马丁.AKT2通过调控p27表达逆转卵巢癌顺铂耐药[J].肿瘤,2008,28(6):459-462. 被引量:2
-
9刘云,杨超,陈萌,李情,姚薇,卢婷,张力国.紫杉醇对犬乳腺肿瘤细胞中Cyclin D1和p27基因表达的影响[J].东北农业大学学报,2013,44(12):73-77. 被引量:2
-
10龚琳,郑莹,刘珊玲,彭芝兰.纤维连接蛋白在卵巢癌多细胞团簇中的作用和顺铂对团簇的影响[J].实用妇产科杂志,2018,34(12):930-934. 被引量:2
同被引文献33
-
1宋晓红,邢辉,翁丹卉,马晓黎,卢运萍,周剑锋,马丁.两位点短发卡状RNA诱导AKT2基因沉默在卵巢癌细胞紫杉醇敏感性中的应用研究[J].肿瘤,2007,27(1):5-8. 被引量:7
-
2No(e)l A,Jost M,Maquoi E.Matrix metalloproteinases at cancer tumor-host interface[J].Semin Cell Dev Biol,2008,19(1):52-60.
-
3Mizutani K,Kofuji K,Shirouzu K.The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer[J].Surg Today,2000,30(7):614-621.
-
4Hirashima Y,Kobayashi H,Suzuki M,et al.Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells[J].J Biol Chem,2003,278(29):26793-26802.
-
5Rieppi M,Vergani V,Gatto C,et al.Mesothelial cells induce the motility of human ovarian carcinoma cells[J].Int J Cancer,1999,80(2):303-307.
-
6Lanfrancone L,Boraschi D,Ghiara P,et al.Human peritoneal mesothelial cells produce many cytokines[granulocyte colony-stimulating factor(CSF),granulocyte-monocyte-CSF,macrophage-CSF,interleukin-1(IL-1),and IL-6] and are activated and stimulated to grow by IL-1[J].Blood,1992,80(11):2835-2842.
-
7Wu H,Cao Y,Weng D,et al.Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms[J].Cancer Letters,2008,271(2):260-271.
-
8Carpenter PM,Dao AV.The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells[J].Anticancer Res,2003,23(5A):3985-3990.
-
9Weng D,Song X,Xing H,et al.Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells[J].Cancer Letters,2009,273(2):257-265.
-
10Hanahan D,Weinberg RA.The hallmarks of cancer[J].Cell,2000,100(1):57-70.
引证文献3
-
1吴卉娟,吴海涛,翁丹卉,邢辉,宋晓红,卢运萍,马丁.PTEN基因增强卵巢癌A2780细胞对紫杉醇敏感性的研究[J].中国癌症杂志,2007,17(9):669-673. 被引量:4
-
2翁艳洁,翁丹卉,夏曦,宋晓红,卢运萍,王世宣,马丁,王常玉.三位点短发卡状RNA在提高RNA干扰效率中的作用[J].中国癌症杂志,2008,18(4):249-253. 被引量:5
-
3翁艳洁,石英,鲍引娣,周文娟,王鸿雁,王常玉.腹膜间皮细胞和卵巢癌细胞A2780的相互作用及对顺铂敏感性的变化[J].医学临床研究,2011,28(4):596-599.
二级引证文献9
-
1肖红卫,刘中华,刘西梅,郑新民,乔宪凤,李莉.两种方法研究不同茎部长度串联shRNA表达载体对EGFP基因的干扰效应[J].江西农业学报,2010,22(10):118-121.
-
2褚艳,岳天孚.卵巢浆液性乳头状囊腺癌中PTEN、survivin和MMP-2的表达及临床意义[J].实用妇产科杂志,2009,25(9):535-537. 被引量:5
-
3褚艳.PTEN和卵巢肿瘤[J].河北医药,2009,31(23):3292-3294. 被引量:1
-
4宋晓红,翁丹卉,邢辉,卢运萍,马丁,王世宣.三位点GSK3β shRNA真核表达质粒的构建及鉴定[J].肿瘤防治研究,2010,37(5):495-499.
-
5陈娴,谢渊,赵艳,周建奖.shRNA表达载体的改建及鉴定[J].基础医学与临床,2011,31(1):78-83.
-
6邓秀娟,吴海根.Ki67、PTEN在卵巢浆液性肿瘤中的表达及临床意义[J].实用癌症杂志,2011,26(4):365-367. 被引量:16
-
7郑新民,刘中华,程妮,肖红卫,乔宪凤,毕延震.Differences of the Silencing Effect at Cellular Level and Individual Level[J].Agricultural Science & Technology,2011,12(8):1230-1233.
-
8郑新民,刘中华,程妮,肖红卫,乔宪凤,毕延震.细胞和个体水平沉默效应的差异[J].安徽农业科学,2011,39(29):17792-17794.
-
9邓秀娟,吴海根.PTEN、Ki67在卵巢恶性肿瘤组织中的研究进展[J].现代肿瘤医学,2012,20(10):2182-2184. 被引量:6
-
1彭萍,沈铿,何维,吴鸣,魏薇,郎景和,张素梅,齐锦,胡榆,赵建晴.白细胞介素12转染树突状细胞后与新建卵巢上皮性癌细胞融合的免疫原性研究[J].中华妇产科杂志,2006,41(1):57-61. 被引量:2
-
2“垃圾DNA”能影响疾病严重程度[J].上海医药,2003,24(6):286-286.
-
3张庆英,成文翔.两种配制胶对单链构象多态性筛查AKT2基因突变的影响[J].汕头大学医学院学报,2007,20(2):120-121.
-
4祝宁侠,陈海滨.EZH2在胚胎干细胞和肿瘤方面的研究进展[J].解剖科学进展,2010,16(1):75-78. 被引量:10
-
5刘敏,杨俊,李莉,李书国.RNA干扰在缺血损伤中的研究现状[J].中国老年学杂志,2011,31(3):530-531.
-
6“垃圾DNA”影响健康[J].百科知识,2003(8):29-29.
-
7王舰,罗恩杰.RNAi的作用机制及其在抗病毒领域的应用[J].微生物学杂志,2006,26(1):93-97. 被引量:2
-
8何军林.基于RNAi的新型药物浮出水面[J].国外医学(药学分册),2006,33(1):73-74.
-
9杨超,班玲,王亮,剧蕴慧,申莉瑛,郑咏欣,赵素芬.灵芝孢子治疗裸鼠卵巢癌过程中let-7的表达及意义[J].医学动物防制,2015,31(1):52-53.
-
10苏鹏,赖永榕.RNA干扰技术及其在血液疾病研究中的应用[J].中国医学文摘(内科学),2006,27(2):107-109.